Trial Profile
Post Authorization Non-interventional Study in HIV1-Infected Patients Starting or Already in Treatment With Darunavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Antiretrovirals; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 06 Dec 2012 Actual initiation date changed from May 2009 to Jun 2009 as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2012 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.